Ipsilateral herpes zoster after the first dose of BNT162b2 mRNA COVID-19 vaccine

J Eur Acad Dermatol Venereol. 2021 Oct;35(10):e620-e622. doi: 10.1111/jdv.17422. Epub 2021 Jun 11.
No abstract available

Publication types

  • Letter

MeSH terms

  • BNT162 Vaccine
  • COVID-19 Vaccines
  • COVID-19*
  • Herpes Zoster*
  • Humans
  • RNA, Messenger
  • SARS-CoV-2

Substances

  • COVID-19 Vaccines
  • RNA, Messenger
  • BNT162 Vaccine